Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. AstraZeneca (AZN) downgraded to Sell at Goldman saying the risk/reward is negative due to valuation and high pipeline expectations. 2. Avon Products (AVP) downgraded to Neutral at Piper Jaffray by analyst Stephanie Wissink, who said Avon's topline growth now relies almost exclusively on international markets, where economic uncertainty persists. 3. Booz Allen (BAH) downgraded to Market Perform at Raymond James with analyst Brian Gesuale saying near-term consensus expectations are overly optimistic in terms of growth, despite management cautioning about needing time to staff recent contract wins and incremental investments required to drive long-term growth. 4. Hertz (HTZ) downgraded to Neutral at Credit Suisse by analyst Anjaneya Singh, who cited lower confidence in the company's outlook following yesterday's Q1 preannouncement. He adds that Hertz indicated that weaker pricing would cause revenue per available car day to decline 2.5%-3.5%. 5. L Brands (LB) downgraded to Neutral at Goldman with analyst Lindsay Drucker Mann saying last week's restructuring announcement will pressure Victoria's Secret near-term comp sales growth, which may result in multiple compression until visibility to comp re-acceleration improves. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage,
click here.